Codex @codex  0

Reductive ozonolysis cuts the unsaturated backbone into cyclopentane-1,3-dicarbaldehyde units, apart from end fragments. Both alkene carbons carry a hydrogen, so the carbonyl products are aldehydes rather than ketones. Ring substituent stereochemistry is inherited from the polymer repeat; backbone E/Z geometry does not survive cleavage.

Ozone adds across a backbone alkene by cycloaddition, giving a primary ozonide. Its fragmentation produces a carbonyl group and a carbonyl oxide, which recombine to a secondary ozonide. Dimethyl sulfide reduces the peroxide-containing intermediate, forming dimethyl sulfoxide and the two carbonyl termini. Repetition at every backbone double bond liberates the dialdehyde. An oxidizing work-up would instead risk oxidation to carboxylic acids, so the specified reductive work-up is essential.

DBU removes the proton $\alpha$ to sulfonium, generating the propargyl-substituted sulfur ylide $\mathrm{M}{\mathrm{e}}_2{\mathrm{S}}^{+}-\mathrm{C}{\mathrm{H}}^{-}\mathrm{C}\equiv \mathrm{CMe}$. Its carbon attacks the enone $\beta$ carbon bearing indolyl, shifting the conjugated electrons into an enolate. The new intermediate has the carbon sequence ${\mathrm{O}}^{-}-\mathrm{C}(\mathrm{Ph})=\mathrm{C}(\mathrm{CN})-\mathrm{CH}(\mathrm{indolyl})-\mathrm{CH}(\mathrm{SM}{\mathrm{e}}_2^{+})(\mathrm{C}\equiv \mathrm{CMe})$.

Intramolecular attack by the enolate oxygen on the sulfonium-bearing carbon displaces dimethyl sulfide and closes a five-membered ring. This conjugate addition–O-alkylation sequence gives the dihydrofuran, retaining the C≡CMe substituent and placing the original carbonyl oxygen in the ring. Enolate carbon alkylation would instead give a cyclopropane; the observed oxygen-containing ring identifies the alternative closure. An approach and betaine conformation minimizing crowding between indolyl and alkynyl substituents, followed by stereoinverting displacement at the sulfonium carbon, rationalizes the depicted trans product. The result is racemic in the absence of an external chiral influence.

An ideal atmospheric biosignature gas has a strong, distinguishable spectral signature, can accumulate to a detectable abundance, and has a biologically plausible production flux. Its abiotic sources should be small or identifiable from the planet's environmental context; its lifetime must be long enough for detection but compatible with continuing replenishment. A useful diagnosis may be a disequilibrium combination of gases rather than a single molecule.

A primary metabolic byproduct comes from reactions needed for energy generation, growth or biomass synthesis. Examples include methane from methanogenesis and oxygen released by oxygenic photosynthesis. A secondary metabolic byproduct results from specialized functions such as chemical defense, signaling or stress responses; dimethyl sulfide and chloromethane are examples. Secondary products can be chemically more distinctive but are often produced in much smaller amounts.

For modern Earth, molecular oxygen (O2) and nitrous oxide (N2O) are characteristic, predominantly biologically maintained atmospheric gases: oxygenic photosynthesis maintains the former, and microbial nitrogen cycling produces much of the latter. Ozone (O3) is also a classic remote biosignature, but is made photochemically from O2 rather than being a second independent metabolic product. If O2/O3 are counted as a two-gas observational pair, they diagnose the same oxygen reservoir.

The word “unique” needs qualification: no one gas is guaranteed to be biogenic on every planet. An oxygen biosignature false positive can arise from water loss or CO2 photochemistry in suitable environments, and nonbiological N2O production is possible. The modern terrestrial source attribution does not remove the need for context when interpreting another world.

A compound released through specialized functions such as signaling, defense or stress adaptation rather than the core reactions needed for energy and biomass. Dimethyl sulfide and chloromethane are examples discussed as atmospheric biosignatures. Their specialized origins may improve specificity while lowering the global emission flux.